表紙
市場調查報告書

臨床營養市場 - 成長,趨勢及預測(2019年 - 2024年)

Clinical Nutrition Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 353821
出版日期 內容資訊 英文 127 Pages
商品交期: 2-3個工作天內
價格
臨床營養市場 - 成長,趨勢及預測(2019年 - 2024年) Clinical Nutrition Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年04月01日內容資訊: 英文 127 Pages
簡介

全球臨床營養市場預計將以6.0%的年複合成長率成長。代謝性疾病的罹患率增加,對醫療保健的高額支出,及新興國家的中產階級崛起等,為該市場的成長要素。

本報告提供全球臨床營養市場的相關調查,市場機會和趨勢,成長及阻礙因素,各投藥途徑、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查的成果
  • 調查的假設
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 代謝性疾病的罹患率增加
    • 對醫療的高額支出
    • 新興國家的中產階級崛起
  • 市場阻礙因素
    • 醫院及院內藥局/調劑藥局不讚成維持臨床營養產品的必要庫存
    • 各種國家的政府的補償範圍/償付的不均勻性
    • 關於臨床營養的不正確認識
    • 出生率低
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各投藥途徑
    • 口服及經腸
    • 非口服
  • 各用途
    • 營養失調的營養支援
    • 代謝性疾病的營養支援
    • 消化器官疾病的營養支援
    • 神經疾病的營養支援
    • 癌症的營養支援
    • 其他
  • 各終端用戶
    • 兒童
    • 成人
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Nutrition
    • Nestle Health Science
    • Baxter Healthcare
    • B. Braun Melsungen AG
    • Nutricia
    • BASF SE
    • Perrigo Company PLC
    • Fresenius Kabi

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 49989

Market Overview

The global clinical nutrition market is expected to witness a CAGR of 6.0%. There are certain factors propelling the growth of the market that includes the increasing prevalence of metabolic disorders, high spending on healthcare and the rise of the middle class in emerging economies.

Over the past decade, the prevalence of metabolic disorders has increased, in terms of raw data. The actual number of patients opting for the diagnosis of metabolic disorders has increased over the last decade, thereby resulting in an increase in the number of patients diagnosed. Thus, with the rising prevalence of metabolic diseases, there is a great opportunity for market players to tap the emerging markets and establish their presence.

It has also been observed that healthcare expenditure continues to grow faster than economic growth in most of the countries, maintaining a trend observed over the decades. Therefore, as healthcare spending increases among major countries of the world, because of its wide applicability, the market is expected to witness high growth.

There are many funding opportunities for clinical nutrition from governments across the globe, including private foundations and the international community. The major funding organizations are - National Institutes of Health, US Department of Agriculture, Robert Woods Johnson Foundation, and Nestle Foundation. These funding opportunities are found propelling the growth of the market.

Scope of the Report

Clinical malnutrition is a disease condition that can be treated only with clinical intervention, through the use of specialized nutrients that are considered as proper medications, rather than as supplements. Clinical nutrition products thus help to keep the patient healthy and aids to improve the metabolic system of the body by providing adequate supplements such as minerals, vitamins, and others. Additionally, the high birth rate and a higher number of premature births also demand advanced clinical nutrition.

Key Market Trends

Oral and Enteral is Expected to Show the Fastest Growth in the Route of Administration

The oral and enteral route of administration accounts for the largest share as they are used the most, followed by a parenteral route. This is mainly because of the additional cost of processing the product/nutrient involved in enteral/parenteral routes.

Therefore like the other routes of administration, physicians also prefer mostly the oral route, as it involves lesser complexities and costs, compared to the other two routes of administration. In addition, in most of the disease conditions like chronic conditions and not acute conditions, the oral route is being preferred thereby driving the overall market.

Asia-Pacific holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

Asia-Pacific has the highest growth in comparison to the other regions in the forecast period mainly due to high levels of malnutrition, and the presence of severe chronic diseases, in the region. Thus due to the increased metabolic disorders and rising income inequality in various countries, the region is also expected to witness robust growth over the forecast period.

Competitive Landscape

The industry players are found focusing on expansion through various inorganic strategies such as acquisition, merger, strategic collaboration, and others to gain significant market share and to strengthen their product portfolios. Thus the growing awareness about clinical nutrition has boosted the demand for pediatric, as well as adult nutrition formulae.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Metabolic Disorders
    • 4.2.2 High Spending on Healthcare
    • 4.2.3 Rise of Middle-class in Emerging Economies
  • 4.3 Market Restraints
    • 4.3.1 Unwillingness of Hospitals and in-house Pharmacies/ Dispensaries to Maintain the Required Stock of Clinical Nutrition Products
    • 4.3.2 Heterogeneous Nature of Government Coverage/Reimbursement across Various Countries
    • 4.3.3 Imprecise Perception about Clinical Nutrition
    • 4.3.4 Reduction in Birth Rates
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Route of Administration
    • 5.1.1 Oral & Enteral
    • 5.1.2 Parenteral
  • 5.2 By Application
    • 5.2.1 Nutritional Support in Malnutrition
    • 5.2.2 Nutritional Support in Metabolic Disorders
    • 5.2.3 Nutritional Support in Gastrointestinal Diseases
    • 5.2.4 Nutritional Support in Neurological Diseases
    • 5.2.5 Nutritional Support in Cancer
    • 5.2.6 Nutritional Support in Others
  • 5.3 By End User
    • 5.3.1 Pediatric
    • 5.3.2 Adult
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Nutrition
    • 6.1.2 Nestle Health Science
    • 6.1.3 Baxter Healthcare
    • 6.1.4 B. Braun Melsungen AG
    • 6.1.5 Nutricia
    • 6.1.6 BASF SE
    • 6.1.7 Perrigo Company PLC
    • 6.1.8 Fresenius Kabi

7 MARKET OPPORTUNITIES AND FUTURE TRENDS